Intro
Each year, approximately 400 000 children worldwide and 1200 in Poland receive a diagnosis of cancer, and there is a consistent increase in incidence [ 1 , 2 ]. The most common childhood cancers are hematological diseases, primarily leukemias [ 3 ]. Conditions that can accompany or even precede the development of cancer by many months and years are classified as paraneoplastic syndromes (PNS). PNS are defined as a group of symptoms occurring together with oncological disease, but not resulting from direct infiltration or the development of metastases, but rather from the release of hormones and peptides that affect host metabolic pathways or from immune system cross-reactions with neoplastic cells [ 4 ]. PNS is estimated to occur in up to 15% of oncological patients, being the second most common cause of mortality in this group (27%). Unfortunately, exact statistics for pediatric patients are not known [ 4 ]. Studies describing PNS in adults are common, but publications regarding pediatric patients are rare. Recognizing PNS is extremely important, as cancers in the pediatric group are curable in as much as 85.7% of patients [ 5 ]. PNS in children can involve all organs but most commonly involve the nervous system, skin, and hematopoietic system. PNS can accompany all cancers, but the largest number of described cases are Hodgkin lymphoma (HL), acute leukemia, and neuroblastoma. Oncological diagnosis of PNS should begin simultaneously with the diagnosis of the symptom itself, as part of so-called oncological vigilance. PNS treatment mainly includes treatment of the underlying disease and immunosuppressive therapy [ 6 , 7 ]. This article aims to review PNS in children with malignancy.
Other
PNS in pediatric patients are extremely rare. Epidemiological studies on larger groups of patients are definitely lacking on this topic. Further case reports and reviews are also needed to identify risk factors and effective therapeutic approaches in pediatric patients with PNS. It would also be useful to have guidelines that address precisely the diagnostic algorithms for each syndrome, as well as the features that would prompt the moment when oncologic diagnosis should be initiated.
Conclusions
PNS are not common phenomena but have remarkable diagnostic value. They can affect almost any system of the body. They often precede overt symptoms and cancer diagnosis by up to several months or years. Therefore, any symptom or, even more so, a set of symptoms that do not respond to the typical treatment or occur in high-risk patients should alert the physician to the need for extended early diagnosis in search of cancer. This is extremely important among pediatric patients because of the incredibly high cure rate of more than 80% for all types of cancer and the higher success of therapy if the disease is detected quickly.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.